Cargando…

Machine Learning to Calculate Heparin Dose in COVID-19 Patients with Active Cancer

To realize a machine learning (ML) model to estimate the dose of low molecular weight heparin to be administered, preventing thromboembolism events in COVID-19 patients with active cancer. Methods: We used a dataset comprising 131 patients with active cancer and COVID-19. We considered five ML model...

Descripción completa

Detalles Bibliográficos
Autores principales:	Imbalzano, Egidio, Orlando, Luana, Sciacqua, Angela, Nato, Giuseppe, Dentali, Francesco, Nassisi, Veronica, Russo, Vincenzo, Camporese, Giuseppe, Bagnato, Gianluca, Cicero, Arrigo F. G., Dattilo, Giuseppe, Vatrano, Marco, Versace, Antonio Giovanni, Squadrito, Giovanni, Di Micco, Pierpaolo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8746167/ https://www.ncbi.nlm.nih.gov/pubmed/35011959 http://dx.doi.org/10.3390/jcm11010219

Ejemplares similares

Sex-Specific Impact of Different Obesity/Metabolic Phenotypes on Long-Term Cardiovascular Outcomes in Acute Coronary Syndrome Patients
por: Imbalzano, Egidio, et al.
Publicado: (2022)

Natural Course of COVID-19 and Independent Predictors of Mortality
por: Orlando, Luana, et al.
Publicado: (2023)

Prevalence of Pulmonary Hypertension in an Unselected Community-Based Population: A Retrospective Echocardiographic Study—RES-PH Study
por: Imbalzano, Egidio, et al.
Publicado: (2021)

Heparin and SARS-CoV-2: Multiple Pathophysiological Links
por: Di Micco, Pierpaolo, et al.
Publicado: (2021)

Special Issue “COVID-19 and Thrombosis”
por: Di Micco, Pierpaolo, et al.
Publicado: (2022)

Editorial on the Special Issue “The New Frontier of Venous Thromboembolism”
por: Di Micco, Pierpaolo, et al.
Publicado: (2023)

Clinical Differences between COVID-19 and a COVID-Like Syndrome
por: Di Micco, Pierpaolo, et al.
Publicado: (2021)

Correction: Di Micco et al. Clinical Differences between COVID-19 and a COVID-like Syndrome. J. Clin. Med. 2021, 10, 2519
por: Di Micco, Pierpaolo, et al.
Publicado: (2022)

The Impact of Risk-Adjusted Heparin Regimens on the Outcome of Patients with COVID-19 Infection. A Prospective Cohort Study
por: Di Micco, Pierpaolo, et al.
Publicado: (2021)

Pathophysiology of Vaccine-Induced Prothrombotic Immune Thrombocytopenia (VIPIT) and Vaccine-Induced Thrombocytopenic Thrombosis (VITT) and Their Diagnostic Approach in Emergency
por: Di Micco, Pierpaolo, et al.
Publicado: (2021)

Case report: Successful thromboprophylaxis with enoxaparin in a pregnant woman with internal jugular vein agenesis
por: Di Micco, Pierpaolo, et al.
Publicado: (2022)

Editorial Comment on the Special Issue Discussing COVID-19 and Thrombosis, Second Edition
por: Di Micco, Pierpaolo, et al.
Publicado: (2023)

Update on the clinical use of the low-molecular-weight heparin, parnaparin
por: Camporese, Giuseppe, et al.
Publicado: (2009)

New-Onset Atrial Fibrillation and Early Mortality Rate in COVID-19 Patients: Association with IL-6 Serum Levels and Respiratory Distress
por: Bagnato, Gianluca, et al.
Publicado: (2022)

Safety and Efficacy of Rivaroxaban as Extended-Phase Anticoagulation in Patients with Cancer and Venous Thromboembolism: A Preliminary Data Analysis from the Mac Project
por: Bernardi, Enrico, et al.
Publicado: (2022)

Safety and Efficacy of Rivaroxaban for Extended-Phase Anticoagulation of Patients with Unprovoked or Recurrent Venous Thromboembolism: Real-Life Data from the MAC Project
por: Bortoluzzi, Cristiano, et al.
Publicado: (2022)

Editorial: Vascular malformations and thrombosis
por: Di Micco, Pierpaolo, et al.
Publicado: (2023)

Rivaroxaban as an effective alternative to warfarin in a patient with atrial fibrillation, thrombophilia, and left atrial appendage thrombus: a case report
por: Scarano, Michele, et al.
Publicado: (2017)

Management of High Cardiovascular Risk in Diabetic Patients: Focus on Low Density Lipoprotein Cholesterol and Appropriate Drug Use in General Practice
por: Rottura, Michelangelo, et al.
Publicado: (2021)

Expression and Change of miRs 145, 221 and 222 in Hypertensive Subjects Treated with Enalapril, Losartan or Olmesartan
por: Mandraffino, Giuseppe, et al.
Publicado: (2021)

Common Practice in the Treatment of Superficial Vein Thrombosis Involving the Sapheno-Femoral Junction: Results from a National Survey of the Italian Society of Angiology and Vascular Medicine (SIAPAV)
por: Camporese, Giuseppe, et al.
Publicado: (2023)

Alarmins as a Possible Target of Future Therapies for Atrial Fibrillation
por: Imbalzano, Egidio, et al.
Publicado: (2022)

Abnormal left ventricular global strain during exercise-test in young healthy smokers
por: Mandraffino, Giuseppe, et al.
Publicado: (2020)

The Impact of COVID-19 Pandemic on Hospitalization and Interventional Procedures for Cardiovascular Diseases during the First Wave in Italy
por: Russo, Vincenzo, et al.
Publicado: (2022)

Vitamin D Status in Rheumatoid Arthritis: Inflammation, Arterial Stiffness and Circulating Progenitor Cell Number
por: Lo Gullo, Alberto, et al.
Publicado: (2015)

Autologous Haematopoietic Stem Cell Transplantation and Systemic Sclerosis: Focus on Interstitial Lung Disease
por: Bagnato, Gianluca, et al.
Publicado: (2022)

Pharmacological Treatment of Diabetic and Non-Diabetic Patients With Coronary Artery Disease in the Real World of General Practice
por: Rottura, Michelangelo, et al.
Publicado: (2022)

Assessment of Apolipoprotein(a) Isoform Size Using Phenotypic and Genotypic Methods
por: Fogacci, Federica, et al.
Publicado: (2023)

Effects of Sacubitril-Valsartan on Clinical, Echocardiographic, and Polygraphic Parameters in Patients Affected by Heart Failure With Reduced Ejection Fraction and Sleep Apnea
por: Pelaia, Corrado, et al.
Publicado: (2022)

Unmet Clinical Needs in Elderly Patients Receiving Direct Oral Anticoagulants for Stroke Prevention in Non-valvular Atrial Fibrillation
por: Botto, Gianluca, et al.
Publicado: (2021)

The COVID-19 Assessment for Survival at Admission (CASA) Index: A 12 Months Observational Study
por: Bagnato, Gianluca, et al.
Publicado: (2021)

PCSK9 Plasma Levels Are Associated with Mechanical Vascular Impairment in Familial Hypercholesterolemia Subjects without a History of Atherosclerotic Cardiovascular Disease: Results of Six-Month Add-On PCSK9 Inhibitor Therapy
por: Toscano, Arianna, et al.
Publicado: (2022)

Management of High-Risk Hypercholesterolemic Patients and PCSK9 Inhibitors Reimbursement Policies: Data from a Cohort of Italian Hypercholesterolemic Outpatients
por: Fogacci, Federica, et al.
Publicado: (2022)

Serum endocan as a predictive biomarker of cardiovascular risk in obese pediatric patients
por: Morace, Carmela, et al.
Publicado: (2023)

Retargeting the management of hypercholesterolemia – focus on evolocumab
por: Colletti, Alessandro, et al.
Publicado: (2016)

Edoxaban for the Long‐Term Therapy of Venous Thromboembolism: Should the Criteria for Dose Reduction be Revised?
por: Camporese, Giuseppe, et al.
Publicado: (2020)

Heparin-like effect in postcardiotomy extracorporeal membrane oxygenation patients
por: Ranucci, Marco, et al.
Publicado: (2014)

Potential Benefits of Berberine in the Management of Perimenopausal Syndrome
por: Caliceti, Cristiana, et al.
Publicado: (2015)

Fatty Liver as Potential Biomarker of Atherosclerotic Damage in Familial Combined Hyperlipidemia
por: Mandraffino, Giuseppe, et al.
Publicado: (2022)

Non-Anticoagulant Heparins as Heparanase Inhibitors
por: Cassinelli, Giuseppe, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8kadnmt57q53m4ktdtr6lm3ptb